Scholarlink

<p>Respiratory diseases encompass a broad range of conditions that affect the airways, alveolus, and other structures involved in breathing. With respiratory viruses emerging and spreading rapidly, and factors like air pollution, smoking, occupational hazards, and genetics as major risk contributors, respiratory diseases have emerged as a primary cause of illness and mortality around the globe. The development of in vitro respiratory microphysiological systems (MPS), like lung organoids and lung-on-a-chip models, is essential for preventing and treating these diseases effectively. In this review, we introduce the generation of lung organoids from different cellular sources and their applications in modeling lung development, disease models, and drug screening. Then, we discuss the establishment of various types of lung-on-a-chip models and their applications in disease modeling and drug screening. Finally, we outline the challenges confronting respiratory MPS and provide an outlook on their future perspectives.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Respiratory microphysiological system in respiratory research: recent advances and future prospects

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2025年7月26日

查看全文
  • Jiaxiang Yin,
  • Zirong Bi,
  • Tiankai Dai,
  • Xiaoyue Zhu,
  • Tao Xu,
  • Huisheng Liu

摘要

Respiratory diseases encompass a broad range of conditions that affect the airways, alveolus, and other structures involved in breathing. With respiratory viruses emerging and spreading rapidly, and factors like air pollution, smoking, occupational hazards, and genetics as major risk contributors, respiratory diseases have emerged as a primary cause of illness and mortality around the globe. The development of in vitro respiratory microphysiological systems (MPS), like lung organoids and lung-on-a-chip models, is essential for preventing and treating these diseases effectively. In this review, we introduce the generation of lung organoids from different cellular sources and their applications in modeling lung development, disease models, and drug screening. Then, we discuss the establishment of various types of lung-on-a-chip models and their applications in disease modeling and drug screening. Finally, we outline the challenges confronting respiratory MPS and provide an outlook on their future perspectives.